• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非接触式经巩膜Nd:YAG睫状体光凝术后视力丧失的相关因素。

Factors associated with visual acuity loss after noncontact transscleral Nd:YAG cyclophotocoagulation.

作者信息

Youn J, Cox T A, Allingham R R, Shields M B

机构信息

Joseph M. Bryan Glaucoma Clinic, Duke University Eye Center, Durham, North Carolina, USA.

出版信息

J Glaucoma. 1996 Dec;5(6):390-4.

PMID:8946295
Abstract

PURPOSE

To determine the factors associated with visual acuity loss following transscleral Nd:YAG cyclophotocoagulation (TYC).

METHODS

The authors retrospectively studied 479 patients followed for a mean of 22 months after the initial TYC in one eye and analyzed the data with univariate and multivariate analysis for the factors associated with visual acuity loss. Data analyzed included age, race, sex, preoperative intraocular pressure (IOP) and visual acuity, type of glaucoma, total energy per treatment, number of retreatments, final IOP, and duration of follow-up.

RESULTS

The preoperative factors associated with visual acuity loss after TYC as determined by both univariate and multivariate analysis were neovascular glaucoma (p = 0.001, odds ratio = 2.80) and black race (p = 0.044, odds ratio = 1.67). Postoperative hypotony and follow-up of > 6 months were also associated with visual acuity loss (p < 0.001, odds ratio = 6.68 and p = 0.046, odds ratio = 2.61, respectively).

CONCLUSIONS

Transscleral Nd:YAG cyclophotocoagulation is associated with a greater risk of visual acuity loss in patients with neovascular glaucoma and in the black population. Postoperative hypotony is associated with a poor visual outcome, whereas the association with longer follow-up duration suggests that other factors, related to the patient's underlying disease, are also significant factors.

摘要

目的

确定经巩膜Nd:YAG睫状体光凝术(TYC)后视力丧失的相关因素。

方法

作者回顾性研究了479例患者,这些患者单眼首次接受TYC治疗后平均随访22个月,并对与视力丧失相关的因素进行单因素和多因素分析。分析的数据包括年龄、种族、性别、术前眼压(IOP)和视力、青光眼类型、每次治疗的总能量、再次治疗次数、最终眼压和随访时间。

结果

单因素和多因素分析确定的TYC后与视力丧失相关的术前因素为新生血管性青光眼(p = 0.001,比值比 = 2.80)和黑人种族(p = 0.044,比值比 = 1.67)。术后低眼压和随访时间>6个月也与视力丧失相关(分别为p < 0.001,比值比 = 6.68和p = 0.046,比值比 = 2.61)。

结论

经巩膜Nd:YAG睫状体光凝术在新生血管性青光眼患者和黑人人群中导致视力丧失的风险更高。术后低眼压与视力预后不良相关,而与较长随访时间的关联表明,与患者基础疾病相关的其他因素也是重要因素。

相似文献

1
Factors associated with visual acuity loss after noncontact transscleral Nd:YAG cyclophotocoagulation.非接触式经巩膜Nd:YAG睫状体光凝术后视力丧失的相关因素。
J Glaucoma. 1996 Dec;5(6):390-4.
2
Comparison of mitomycin C trabeculectomy, glaucoma drainage device implantation, and laser neodymium:YAG cyclophotocoagulation in the management of intractable glaucoma after penetrating keratoplasty.穿透性角膜移植术后难治性青光眼治疗中丝裂霉素C小梁切除术、青光眼引流装置植入术及激光钕:钇铝石榴石睫状体光凝术的比较
Ophthalmology. 1998 Aug;105(8):1550-6. doi: 10.1016/S0161-6420(98)98046-0.
3
Contact transscleral diode cyclophotocoagulation for refractory glaucoma.经巩膜接触式二极管睫状体光凝术治疗难治性青光眼
J Glaucoma. 1999 Feb;8(1):3-7.
4
Noncontact transscleral Nd:YAG cyclophotocoagulation: a long-term follow-up of 500 patients.非接触式经巩膜Nd:YAG睫状体光凝术:500例患者的长期随访
Trans Am Ophthalmol Soc. 1994;92:271-83; discussion 283-7.
5
Transscleral neodymium:YAG cyclophotocoagulation: comparison of 180-degree and 360-degree initial treatments.经巩膜钕:钇铝石榴石激光睫状体光凝术:180度和360度初始治疗的比较
Ophthalmic Surg. 1993 Mar;24(3):181-4.
6
Risk factors for hypotony after transscleral diode cyclophotocoagulation.经巩膜二极管光凝术后低眼压的危险因素。
J Glaucoma. 2012 Mar;21(3):169-73. doi: 10.1097/IJG.0b013e318207091a.
7
Transscleral neodymium:YAG laser cyclophotocoagulation for end-stage glaucoma, refractory glaucoma, and painful blind eyes.经巩膜钕:钇铝石榴石激光睫状体光凝术治疗终末期青光眼、难治性青光眼和疼痛性盲眼。
Ophthalmic Surg. 1993 Aug;24(8):526-9.
8
Transscleral cyclophotocoagulation with the diode laser for neovascular glaucoma.二极管激光经巩膜睫状体光凝术治疗新生血管性青光眼。
Ophthalmic Surg Lasers. 1998 Sep;29(9):722-7.
9
[Diode laser cyclophotocoagulation in treatment of therapy refractory glaucoma].二极管激光睫状体光凝术治疗难治性青光眼
Klin Monbl Augenheilkd. 1997 Oct;211(4):250-6. doi: 10.1055/s-2008-1035131.
10
Long-term results of noncontact neodymium:yttrium-aluminum-garnet cyclophotocoagulation in neovascular glaucoma.非接触式钕钇铝石榴石激光睫状体光凝术治疗新生血管性青光眼的长期疗效
Ophthalmology. 2003 May;110(5):895-9. doi: 10.1016/S0161-6420(03)00103-9.

引用本文的文献

1
A retrospective analysis of long-term outcomes following a single episode of transscleral cyclodiode laser treatment in patients with glaucoma.青光眼患者单次经巩膜睫状体光凝治疗后的长期疗效回顾性分析。
BMJ Open. 2013 Jul 6;3(7). doi: 10.1136/bmjopen-2013-002793. Print 2013.
2
Contact transscleral neodymium:yttrium-aluminum-garnet laser cyclophotocoagulation Long-term outcome.经巩膜接触钕:钇铝石榴石激光睫状体光凝术的长期疗效。
Ophthalmology. 2004 Nov;111(11):2137-43. doi: 10.1016/j.ophtha.2004.05.027.
3
Transscleral diode laser cyclophotocoagulation for the treatment of refractory glaucoma secondary to inflammatory eye diseases.
经巩膜二极管激光睫状体光凝术治疗炎症性眼病继发的难治性青光眼
Br J Ophthalmol. 2000 Sep;84(9):999-1003. doi: 10.1136/bjo.84.9.999.